Data / Drug companies / Octinoxate and zinc oxide
Octinoxate and zinc oxide: 8 companies and 12 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Octinoxate and zinc oxide is listed in the FDA National Drug Code Directory by 8 companies, with 12 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are lotion; cream, and the newest product started marketing on September 1, 2025.
The request: Get every company that lists octinoxate and zinc oxide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 8
- Products
- 12
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Topical
- Brand names
- Antioxidant Sunscreen SPF 40, Olay Complete Lightweight With Sunscreen Broad Spectrum SPF 15 Sensitive, Olay Age Defying Classic Broad Spectrum SPF 15, Journee Bio-restorative Day Balm Broad-spectrum Suncreen SPF 30, Olay Age Defying Classic Daily Renewal Broad Spectrum SPF 15, CeraVe Developed With Dermatologists Skin Renewing Broad Spectrum SPF 30 Day, Olay Complete Uv365 Daily Moisturizer Sensitive Broad Spectrum SPF 15, Nu-Derm Healthy Skin Protection SPF 35
- openFDA record search
- api.fda.gov
Companies that list octinoxate and zinc oxide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Merz North America, Inc. | 2 | lotion | Over the counter monograph drugs | June 1, 2018 |
| Nse Products, Inc. | 2 | lotion | Over the counter monograph drugs | August 1, 2013 |
| The Procter & Gamble Manufacturing Company | 2 | lotion | Over the counter monograph drugs | September 1, 2025 |
| The Procter & Gamble Manufacturing Company | 2 | lotion | Over the counter monograph drugs | September 11, 2017 |
| L'Oreal USA Products Inc | 1 | cream | Over the counter monograph drugs | August 28, 2017 |
| Noxell Corporation | 1 | cream | Over the counter monograph drugs | June 1, 2016 |
| Obagi Cosmeceuticals LLC | 1 | cream | Over the counter monograph drugs | January 1, 2002 |
| Topiderm, Inc. | 1 | lotion | Over the counter monograph drugs | July 28, 2000 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Lotion | 9 | 75% |
| Cream | 3 | 25% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 12 | 100% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.